COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
EMA’s safety committee, PRAC, concluded its preliminary review of a signal of blood clots in people vaccinated with…
EMA’s safety committee, PRAC, concluded its preliminary review of a signal of blood clots in people vaccinated with…
La raccomandazione del Comitato di Valutazione dei rischi per la Farmacovigilanza (PRAC) dell’Agenzia Europea per i Medicinali (EMA),…
Via libera dell’Agenzia europea del farmaco (Ema) al vaccino AstraZeneca. “Il vaccino AstraZeneca è sicuro, efficace, i benefici…